7 results
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
management in Pulmonary ... Hypertension (PAH ... #Hypertension #PAH ... #Management #Algorithm ... #treatment #pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... long-acting β2-agonist; ICS ... #Management #Pulmonary
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... Obstructive Pulmonary ... #Algorithm #Management ... #Pulmonary #LABA ... #Pharmacology
Low / Intermediate Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH
Intermediate Risk Pulmonary ... Hypertension (PAH ... ) Management Algorithm ... #Hypertension #PAH ... #treatment #pharmacology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Imaging: CXR- pulmonary ... Renal Failure Treatment ... organ dysfuxtion, ICU ... diagnosis #management #hematology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
importantly, bedside ultrasound ... with presence of pulmonary ... the treatment goal ... #differential #algorithm ... #clinical #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
amyloidosis, PAH ... Nephrogenic DI Hematologic ... Adenocarcinoma Treatment ... Symptomatic: artificial tears ... lubricants • Pharmacologic